Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ICLE 2022 | T-cell engineering advances at ICLE 2022

Michael Traxlmayr • 1 Apr 2022
ICLE 2022
General CAR-T

Michael Traxlmayr, PhD, University of Natural Resources and Life Sciences, Vienna, Austria, gives his highlights within the burgeoning field of immune cell engineering presented at the International Conference on Lymphocyte Engineering (ICLE) 2022. Notable advances include developing cellular therapies based on Foxp3+ regulatory T (Treg) cells, which will potentially represent the next generation of T-cell therapies. This interview took place at ICLE 2022.

More from Michael Traxlmayr

Expanding the clinical applications of AvidCAR T-cells
1:02
Expanding the clinical applications of AvidCAR T-cells
Michael Traxlmayr • 1 Apr 2022
Developing an AvidCAR platform to improve T-cell activity
0:43
Developing an AvidCAR platform to improve T-cell activity
Michael Traxlmayr • 1 Apr 2022

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals